ZNF703 and breast cancer: We assessed the inhibitory activity of ZNF703-ASO9 on ZNF703 expression in two other BC cell lines (MDA-MB-134, luminal, and MDA-MB-231, basal) to establish its consistency in effectively inhibiting its target gene (Figure 3).